NCT00003176 Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma Status COMPLETED Phase PHASE2
NCT00003173 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE2
NCT00003101 Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma Status COMPLETED Phase PHASE2
NCT00003073 Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors Status UNKNOWN Phase PHASE1
NCT00003067 Biological Therapy in Treating Patients With Primary or Advanced Glioma Status SUSPENDED Phase PHASE2
NCT00003022 Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer Status COMPLETED Phase PHASE1
NCT00003020 LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases Status COMPLETED Phase PHASE1
NCT00003015 Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma Status UNKNOWN Phase PHASE3
NCT00002988 Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma Status COMPLETED Phase PHASE1
NCT00002986 Chemotherapy in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00002971 O(6)-Benzylguanine in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE1
NCT00002965 Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas Status COMPLETED Phase PHASE2
NCT00002947 Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer Status TERMINATED Phase PHASE1
NCT00002931 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Status COMPLETED Phase PHASE2
NCT00002876 Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas Status COMPLETED Phase PHASE2
NCT00002840 Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma Status COMPLETED Phase PHASE3
NCT00002824 Gene Therapy in Treating Patients With Primary Brain Tumors Status COMPLETED Phase PHASE1